| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 10/25/2001 | CA2405557A1 Albumin fusion proteins |
| 10/25/2001 | CA2405550A1 Albumin fusion proteins |
| 10/25/2001 | CA2405525A1 Albumin fusion proteins |
| 10/25/2001 | CA2405377A1 Nutritional modules |
| 10/24/2001 | EP1146885A1 Pre-conditioning against cell death |
| 10/24/2001 | EP1146870A1 Antioxidant compositions and methods for companion animals |
| 10/24/2001 | EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 10/23/2001 | US6307080 Water-soluble zinc pyruvates or their hydrates, method for the product ion thereof and their use |
| 10/23/2001 | CA2080343C 5-benzyl barbiturate derivatives |
| 10/18/2001 | WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS |
| 10/18/2001 | WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 10/18/2001 | WO2001077137A1 Albumin fusion proteins |
| 10/18/2001 | WO2001076584A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 10/18/2001 | WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties |
| 10/18/2001 | US20010031732 Free radical scavenger in cosmetics, drugs |
| 10/18/2001 | US20010031284 Process for extracting antioxidants from anaerobically fermented solid plant waste and extracts prepared thereby |
| 10/18/2001 | US20010031265 Soaking in solution; then culturing |
| 10/18/2001 | DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma |
| 10/18/2001 | CA2405912A1 Albumin fusion proteins |
| 10/18/2001 | CA2405411A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 10/17/2001 | EP1144614A2 33 human secreted proteins |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors |
| 10/17/2001 | CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists |
| 10/16/2001 | US6303610 Method of treating gout with certain indole compounds |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074351A1 Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001018038A3 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 10/11/2001 | WO2000076556A3 High dose radionuclide complexes for bone marrow suppression |
| 10/11/2001 | US20010028899 Composition for supprssing cellular fibrousing and method for preparing an extract from loquat seeds |
| 10/11/2001 | CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/10/2001 | EP1140195A1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof |
| 10/10/2001 | EP1140077A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 10/10/2001 | EP1140006A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 10/10/2001 | EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 10/10/2001 | CN1317015A Human anti-factor IX/IXa antibodies |
| 10/10/2001 | CN1072484C Method for making tablet and granulate containing sodium 2-mercaptoethanesulfonate |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/04/2001 | WO2001072849A1 Per(3,6-anhydro)cyclodextrin derivatives, preparation and use thereof for separating ions |
| 10/04/2001 | WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 10/04/2001 | WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001072327A2 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 10/04/2001 | WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine |
| 10/04/2001 | WO2001072305A1 A medicament and method for the production thereof |
| 10/04/2001 | WO2001072296A1 Method of inhibiting the expression of inflammatory cytokines and chemokines |
| 10/04/2001 | WO2001072291A2 Treatment of movement disorders with metabotropic glutamate receptor antagonist |
| 10/04/2001 | EP1138326A1 Use of synthetic triglycerides based on conjugated linoleic acid in the preparation of agents for the treatment of catabolic conditions |
| 10/04/2001 | EP1138325A1 Use of synthetic triglycerides based on conjugated linoleic acid in the preparation of agents aiding tumour treatment |
| 10/04/2001 | EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 10/04/2001 | CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine |
| 10/04/2001 | CA2404077A1 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 10/04/2001 | CA2404049A1 Treatment of movement disorders |
| 10/04/2001 | CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds |
| 10/03/2001 | CN1315864A Powdery preparation for mucosal administration containing polymeric medicine |
| 10/03/2001 | CN1315835A Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid |
| 10/02/2001 | US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070591A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
| 09/27/2001 | WO2001070248A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 09/27/2001 | WO2001070176A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 09/27/2001 | WO2001032654A3 Novel heterocyclic compounds and their use as medicines |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001012127B1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | WO2000061537A3 Pharmaceutical compounds |
| 09/27/2001 | US20010025032 Administering mixture of nucleosides; anticancer agent |
| 09/27/2001 | US20010024809 Administering phenylpropanoid derivative as nutrient or therapy; cultured from Ajuga plant under aerobic conditions; free radical scavengers |
| 09/27/2001 | CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136073A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 09/26/2001 | EP1135998A1 Use of synthetic triglycerides based on conjugated linoleic acid as antioxydant in foodstuffs |
| 09/26/2001 | EP1135996A1 Use of synthetic triglycerides based on conjugated linoleic acid as colour stabilisor in foodstuffs |
| 09/26/2001 | EP1135519A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 09/26/2001 | EP1135411A1 Methods and compositions for treating disorders involving excitotoxicity |
| 09/26/2001 | EP1135114A1 Method for reducing free-radical induced injury |
| 09/26/2001 | EP1135103A1 Use of plant extracts with an anti-radical-type action |
| 09/26/2001 | EP0966426B1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 09/26/2001 | EP0702558B1 Novel opioid peptide inhibitors |
| 09/26/2001 | CN1314943A Method for producing plants with increased flavonoid and phenolic compound content |
| 09/26/2001 | CN1314893A IL-8 receptor antanonists |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068094A1 Heme oxygenase-1 inducers or induction enhancers |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001030366A3 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 09/20/2001 | US20010023260 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 09/20/2001 | US20010023256 Reducing concentration of oxygen metabolites |
| 09/20/2001 | DE10113205A1 Composition containing antioxidants, useful in foods, cosmetics and pharmaceuticals, is prepared by anaerobic fermentation and extraction of plant material |
| 09/20/2001 | DE10013578A1 Use of 3,4-dihydroxymandelic acid and/or stereoisomers as antioxidants and/or radical scavengers in protecting mammalian skin, cosmetic or pharmaceutical preparations, foodstuffs, lacquers and polymers |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/19/2001 | EP1133487A1 Scavenger compounds |
| 09/19/2001 | EP0874849B1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives |
| 09/19/2001 | EP0594667B1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 09/18/2001 | US6291702 As agents for trapping and identifying free radical species and find use as efficient antioxidants in physicochemical and biological systems. |